SPHACY confidently connects with over 100 businesses at the event “Business Matching Fair 2024”

SPHACY confidently connects with over 100 businesses at the event “Business Matching Fair 2024”

19 August 2024

On August 8, 2024, SPHACY participated in the “Business Matching Fair 2024” event held in Ho Chi Minh City, which brought together nearly 100 businesses from around the world. This is one of the major and prestigious events organized by VietinBank in collaboration with its strategic partner MUFG, aimed at creating a forum for networking, expanding partnerships, and exploring new growth opportunities for businesses.

sphacy-kinh-doanh-toan-cau
SPHACY participated in the “Business Matching Fair 2024” event held in Ho Chi Minh City, organized by VietinBank in collaboration with its strategic partner MUFG.

SPHACY – A Breakthrough Technology Solution for the Pharmaceutical Industry

With a mission to pioneer in providing breakthrough technology solutions for the pharmaceutical industry, SPHACY always aims to create products and services that optimize management processes, enhance customer care quality, and ensure strict compliance with legal regulations. At the “Global Business Connection 2024” event, SPHACY not only had the opportunity to present its solutions but also demonstrated its significant role in shaping the future of the healthcare and pharmaceutical industry.

The pharmaceutical sector is facing numerous challenges, ranging from inventory management and drug quality to meeting GPP (Good Pharmacy Practices) standards. SPHACY, with its advanced technological solutions, is helping pharmacies and pharmaceutical companies optimize every aspect of their business processes. The SPHACY GPP management software is a prime example, assisting businesses in data synchronization, record management, and meeting the highest quality standards.

Expanding the Network, Strengthening International Collaboration

This event is not only an opportunity for SPHACY to meet with current partners but also an occasion for us to seek new collaboration opportunities on a global scale. Expanding our international cooperation network is one of the key strategies that will help SPHACY enhance its position in the domestic market and extend further into international markets. The presence of nearly 100 businesses from various countries has created an ideal environment for SPHACY to share its vision and explore new potentials.

The Importance of the Event in Shaping the Future of the Pharmaceutical Industry

Through discussions, meetings, and exchanges at the event, SPHACY received positive feedback from partner companies regarding the challenges facing the pharmaceutical industry, as well as future development trends. This valuable information helps us continuously improve and develop technological solutions to better meet market and customer demands.

The “Global Business Connection 2024” event also provided SPHACY with the opportunity to learn from leading global companies, gaining valuable experiences that can be applied to our own business practices. In doing so, we will continuously refine and upgrade our products, bringing sustainable value to the pharmaceutical industry.

The pharmaceutical sector is facing numerous challenges, ranging from inventory management and pharmaceutical quality to meeting GPP (Good Pharmacy Practices) standards.

Commitment to Sustainable Development and Contributions to the Pharmaceutical Industry

SPHACY understands that sustainable development comes not only from technology but also from building a strong business community and fostering close collaboration. We are committed to continuing our investment in research and the development of advanced technological solutions to bring practical value to the healthcare industry and public health.

We would also like to extend our gratitude to VietinBank and MUFG for creating a valuable forum that allows businesses to connect and grow together. This event will be a crucial stepping stone for SPHACY to advance further on the path to becoming a reliable and pioneering partner in the pharmaceutical technology sector.